Document:

Exhibit 4.14

 

THIS WARRANT AND THE SHARES OF COMMON STOCK
WHICH MAY BE PURCHASED UPON THE EXERCISE OF THIS WARRANT HAVE BEEN ACQUIRED SOLELY FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR
SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL
THAT SUCH SALE, OFFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT AND OF
ANY APPLICABLE STATE SECURITIES LAWS.

 

BONNE SANTE GROUP, INC.

 

COMMON STOCK PURCHASE WARRANT

 

DATED, as of December 18,
2020

 

 

 

	Holder: PEAH CAPITAL, LLC	Number of Warrants: 1,292,445

 

 

 

THIS CERTIFIES
THAT Holder is the owner of the number of Warrants set forth above of Bonne Santé Group, Inc., a Delaware corporation (hereinafter
called the “Company”). Each Warrant entitles the Holder to purchase one share (collectively the “Warrant Shares”)
of the common stock of the Company (“Common Stock”) at an exercise price per share of $0.0001 per share (the
“Exercise Price”) at any time during the period commencing on December 18, 2020 and ending on December
18 2025 (the “Expiration Date”). The number of warrants listed above shall be increased in the event the Company issues
any additional shares of Common Stock prior to the effective date of any registration statement filed with the Securities and Exchange
Commission (the “Effective Date”). The increased warrants shall be equal to the difference between 1,292,445 and that number
of warrants which would equal 9.9% of the Company’s outstanding capitalization immediately preceding the Effective Date.

 

Notwithstanding
the foregoing, this Warrant shall automatically expire and terminate in the event (i) the Company files and has declared effective a registration
statement under the Act covering the resale of all shares issued pursuant to that certain Future Equity Agreement between the parties
also dated as of December 18, 2020 (“the Share Registration”) or (ii) in the 17 months following the issuance date of this
Warrant, the Company does not borrow, in the aggregate, at least $1,200,000 from the Holder pursuant to that certain LOAN AND SECURITY
AGREEMENT dated December 18, 2020.

 

 1. Method of Exercise; Payment.

 

(a) 
Cash Exercise. The purchase rights represented by this Warrant may be exercised by the Holder, in whole or in part, by the
surrender of this Warrant (with the notice of exercise form attached hereto as Exhibit A duly executed) at the principal office of the
Company, and by the payment to the Company, by certified, cashier’s or other check acceptable to the Company or by wire transfer
to an account designated by the Company, of an amount equal to the aggregate Exercise Price of the Warrant Shares being purchased.

 

(b) 
Net Issue Exercise. In lieu of exercising this Warrant, the Holder may elect to receive Warrant Shares equal to the value
of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with
notice of such election, in which event the Company shall issue to the Holder a number of Warrant Shares computed using the following
formula:

 

	 	 	 	
    Y (A-B)

    X = ——————— 

	 	 	 	A                  
	 	 	 	 
	Where:	X	=	the number of the Warrant Shares to be issued to the Holder.
	 	Y	=	the number of the Warrant Shares purchasable under this Warrant.
	 	A	=	the fair market value of one Share on the date of determination.
	 	B	=	the per share Exercise Price
(as adjusted to the date of such calculation). 

 

     

     

    

 

 (c) Fair
Market Value. For purposes of this Section 1, the per share fair market value of the Warrant Shares shall mean:

 

(i)
If the Company’s Common Stock is publicly traded, the per share fair market value of the Warrant Shares shall be the average
of the closing prices of the Common Stock as quoted on the or the principal exchange on which the Common Stock is listed, in each case
for the three trading days immediately prior to the date the submission of an exercise notice;

 

(ii) 
If the Company’s Common Stock is not so publicly traded, the per share fair market value of the Warrant Shares shall be such
fair market value as is determined in good faith by the Board of Directors of the Company after taking into consideration factors it deems
appropriate, including, without limitation, recent sale and offer prices of the capital stock of the Company in private transactions negotiated
at arm’s length.

 

(d) Stock
Certificates. In the event of any exercise of the rights represented by this Warrant, certificates for the Warrant Shares so
purchased shall be delivered to the Holder within a reasonable time and, unless this Warrant has been fully exercised or has
expired, a new Warrant representing the Warrant Shares with respect to which this Warrant shall not have been exercised shall also
be issued to the Holder within such time.

 

2.
Stock Fully Paid; Reservation of Shares. All of the Warrant Shares issuable upon the exercise of the rights represented by
this Warrant will, upon issuance and receipt of the Exercise Price therefor, be fully paid and nonassessable, and free from all taxes,
liens and charges with respect to the issue thereof. During the period within which the rights represented by this Warrant may be exercised,
the Company shall at all times have authorized and reserved for issuance sufficient shares of its Common Stock to provide for the exercise
of the rights represented by this Warrant.

 

3. 
Adjustments. The number and kind of securities purchasable upon the exercise of this Warrant and the Exercise Price therefor
shall be subject to adjustment from time to time upon the occurrence of certain events, as follows:

 

(a)  Reclassification.
In the case of any reclassification or change of securities of the class issuable upon exercise of this Warrant (other than a change
in par value, or from par value to no par value, or from no par value to par value, or as a result of a subdivision or combination),
or in case of any merger of the Company with or into another corporation (other than a merger with another corporation in which the
Company is the acquiring and the surviving corporation and which does not result in any reclassification or change of outstanding
securities issuable upon exercise of this Warrant), or in case of any sale of all or substantially all of the assets of the Company,
the Company, or such successor or purchasing corporation, as the case may be, shall duly execute and deliver to the holder of this
Warrant a new Warrant (in form and substance reasonably satisfactory to the holder of this Warrant), or the Company shall make
appropriate provision without the issuance of a new Warrant, so that the holder of this Warrant shall have the right to receive, at
a total purchase price not to exceed that payable upon the exercise of the unexercised portion of this Warrant, and in lieu of the
Warrant Shares of Common Stock theretofore issuable upon exercise of this Warrant, (i) the kind and amount of shares of stock, other
securities, money and property receivable upon such reclassification, change, merger or sale by a holder of the number of Warrant
Shares of Common Stock then purchasable under this Warrant, or (ii) in the case of such a merger or sale in which the consideration
paid consists all or in part of assets other than securities of the successor or purchasing corporation, at the option of the Holder
of this Warrant, the securities of the successor or purchasing corporation having a value at the time of the transaction equivalent
to the fair market value of the Common Stock at the time of the transaction. The provisions of this subparagraph (a) shall similarly
apply to successive reclassifications, changes, mergers and transfers.

 

(b) 
Stock Splits, Dividends and Combinations. In the event that the Company shall at any time subdivide the outstanding shares
of Common Stock or shall issue a stock dividend on its outstanding shares of Common Stock the number of Warrant Shares issuable upon exercise
of this Warrant immediately prior to such subdivision or to the issuance of such stock dividend shall be proportionately increased, and
the Exercise Price shall be proportionately decreased, and in the event that the Company shall at any time combine the outstanding shares
of Common Stock the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such combination shall be proportionately
decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on the date of such subdivision,
stock dividend or combination, as the case may be.

 

    2

     

    

 

(c) 
Dilutive Issuances. In the event that the number of outstanding shares of Common Stock of the Company is increased between
now and the 18 month anniversary of this Warrant, this number of warrant shares issuable upon exercise of this Warrant shall be automatically
increased to represent that number which is 9.9% of the then total outstanding capitalization.

 

4.
Notice of Adjustments. Whenever the number of Warrant Shares purchasable hereunder or the Exercise Price thereof shall be adjusted
pursuant to Section 3 hereof, the Company shall provide notice to the Holder setting forth, in reasonable detail, the event requiring
the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the number and class of shares which
may be purchased thereafter and the Exercise Price therefor after giving effect to such adjustment.

 

5. 
Fractional Shares. The Company shall not be required to issue fractional shares of Common Stock on the exercise of Warrants.
If more than one Warrant shall be presented for exercise in full at the same time by the same Holder, the number of full shares of Common
Stock which shall be issuable upon such exercise shall be computed on the basis of the aggregate number of shares of Common Stock acquirable
on exercise of the Warrants so presented. If any fraction of a share of Common Stock would, except for the provisions of this Section,
be issuable on the exercise of any Warrant (or specified portion thereof) then such fractional share shall be rounded up to the nearest
whole share.

 

6. 
Representations of the Company. The Company represents that all corporate actions on the part of the Company, its officers,
directors and shareholders necessary for the sale and issuance of the Warrant Shares pursuant hereto and the performance of the Company’s
obligations hereunder were taken prior to and are effective as of the effective date of this Warrant.

 

 7. Representations and Warranties by the Holder. The Holder represents and warrants to the Company as follows:

 

(a) 
This Warrant and the Warrant Shares issuable upon exercise thereof are being acquired for its own account, for investment and not
with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act
of 1933, as amended (the “Act”). Upon exercise of this Warrant, the Holder shall, if so requested by the Company, confirm
in writing, in a form satisfactory to the Company, that the securities issuable upon exercise of this Warrant are being acquired for investment
and not with a view toward distribution or resale.

 

(b) 
The Holder understands that the Warrant and the Warrant Shares have not been registered under the Act by reason of their issuance
in a transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Section 4(2) thereof, and that
they must be held by the Holder indefinitely, and that the Holder must therefore bear the economic risk of such investment indefinitely,
unless a subsequent disposition thereof is registered under the Act or is exempted from such registration.

 

(c)
The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and
risks of an investment in the Warrant and the Warrant Shares purchasable pursuant to the terms of this Warrant and of protecting its interests
in connection therewith.

 

(d) 
The Holder is able to bear the economic risk of the purchase of the Warrant Shares pursuant to the terms of this Warrant.

 

8. 
Restrictive Legend. The Warrant Shares (unless registered under the Act) shall be stamped or imprinted with a legend in substantially
the following form:

 

THE SHARES
REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION
THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT STATING THAT SUCH SALE OR
TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT.

 

    3

     

    

 

 9. Restrictions Upon Transfer and Removal of Legend.

 

(a) 
The Company need not register a transfer of this Warrant or Warrant Shares bearing the restrictive legend set forth in Section
8 hereof, unless the conditions specified in such legend are satisfied. The Company may also instruct its transfer agent not to register
the transfer of the Warrant Shares, unless one of the conditions specified in the legend referred to in Section 8 hereof is satisfied.

 

(b) 
Notwithstanding the provisions of paragraph (a) above, no opinion of counsel shall be necessary for a transfer without consideration
by any holder (i) if such holder is a partnership, to a partner or retired partner of such partnership who retires after the date hereof
or to the estate of any such partner or retired partner, or (ii) if such holder is a corporation, to a shareholder of such corporation,
or to any other corporation under common control, direct or indirect, with such holder.

 

10.
Rights of Shareholders. No holder of this Warrant shall be entitled as a Warrant holder, to vote or receive dividends or be
deemed the holder of any Warrant Shares or any other securities of the Company which may at any time be issuable on the exercise hereof
for any purpose, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights
of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any
meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification
of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or to receive dividends
or subscription rights or otherwise until the Warrant shall have been exercised and the Warrant Shares purchasable upon the exercise hereof
shall have become deliverable, as provided herein. The holder of this Warrant will not be entitled to share in the assets of the Company
in the event of a liquidation, dissolution or the winding up of the Company.

 

11.
Notices. All notices and other communications required or permitted hereunder shall be in writing, shall be effective when
given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S.
Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if
delivered by hand, (c) one business day after the business day of deposit with Federal Express or similar overnight courier, freight
prepaid or (d) one business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy
by first class mail, postage prepaid, and shall be addressed (i) if to the Holder, at the Holder’s address as set forth on the
books of the Company, and (ii) if to the Company, at the address of its principal corporate offices (attention: Alfonso Cervantes,
Chairman), or at such other address as a party may designate by ten days advance written notice to the other party pursuant to the
provisions above.

 

12.
Governing Law. This Warrant and all actions arising out of or in connection with this Agreement shall be governed by and construed
in accordance with the laws of the State of Florida, without regard to the conflicts of law provisions of the State of Florida or of any
other state.

 

    4

     

    

 

	Issued as of 18th day of December 2020.
	 	 
	 	BONNE SANTE GROUP INC.
	 	 
	 	/s/ Alfonso J. Cervantes
	 	Name: 	Alfonso J. Cervantes
	 	Title: 	Chairman
	 	 
	 	HOLDER
	 	 
	 	/s/ Dan Arev
	 	Name: 	Dan Arev
	 	Title: 	Manager

 

    5

     

    

 

EXHIBIT A

 

 

 

NOTICE OF EXERCISE

 

 

 

TO: Bonne Santé Group, Inc.

10575 NW 37 TERRACE

DORAL, FLORIDA 33178

Attention: Alfonso Cervantes

 

1. The undersigned hereby
elects to purchase_____Warrant Shares of Bonne Santé Group, Inc. pursuant to the terms of the attached Warrant.

 

 2. Method of Exercise (Please initial the applicable blank):

 

		☐	The undersigned elects to exercise the attached Warrant by
means of a cash payment, and tenders herewith or by concurrent wire transfer payment in full for the purchase price of the shares being
purchased, together with all applicable transfer taxes, if any.

 

		☐	The undersigned elects to exercise the attached Warrant by
means of the net exercise provisions of Section 1(b) of the Warrant.

 

3. 
Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name
as is specified below:

 

	 	 	 

(Name)

	 	 	 
	 	 	 
	 	

       
	 
	 	 	 

(Address)

 

4. 
The undersigned hereby represents and warrants that the aforesaid Warrant Shares are being acquired for the account of the undersigned
for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present
intention of distributing or reselling such shares and all representations and warranties of the undersigned set forth in Section 7 of
the attached Warrant are true and correct as of the date hereof.

 

	 	Name:
	 	Title:Exhibit
4.15

 

AMENDMENT
NO. 1 TO COMMON STOCK PURCHASE WARRANT

 

AMENDMENT
NO. 1 TO COMMON STOCK PURCHASE WARRANT (“Amendment”) is made as of the 30th day of June, 2021 by and between
Bonne Santé Group, Inc., a Delaware corporation (the “Company”) and the holder listed on the signature
page attached hereto (the “Holder”). Capitalized terms used but not defined herein shall have the meaning ascribed
to them in the Warrant (as defined below).

 

WHEREAS,
the Holder currently holds Warrant (the “Warrant”) to purchase 1,292,445 shares of common stock of the Company,
at an exercise price per share of $0.0001 per share, which is exercisable at any time during the period commencing on December 18, 2020
and ending on December 18 2025;

 

WHEREAS,
the Company and the Holder desire to change the exercise commencement date of the Warrant to January 31, 2022;

 

NOW,
THEREFORE, in consideration of the Amendment and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the undersigned parties hereby agree to amend the Warrant as follows:

 

		1.	The
                                            second sentence of the first paragraph of the Warrant shall be amended and restated in its
                                            entirety as follows:

 

“Each
Warrant entitles the Holder to purchase one share (collectively the “Warrant Shares”) of the common stock of the Company
(“Common Stock”) at an exercise price per share of $0.0001 per share (the “Exercise Price”) at any time during
the period commencing on January 31, 2022 and ending on December 18 2027 (the “Expiration Date”).”

 

		2.	Amended
                                            and Restated Warrant. Upon the request of the Holder and receipt by the Company of the original
                                            Warrant, the Company will provide the Holder with an Amended and Restated Warrant, reflecting
                                            the amendments described herein.

 

		3.	Full
                                            Force and Effect. Except as amended hereby, the Warrant shall remain in full force and effect
                                            in accordance with its original terms.

 

		4.	Governing
                                            Law. This Amendment is governed by the laws of the State of Florida.

 

Remainder
of Page Intentionally Left Blank

 

     

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Common Stock Purchase Warrant as of the date first written above.

 

	 	BONNE
    SANTE GROUP, INC.
	 	 	 
	 	By:
    	/s/
    Alfonso J. Cervantes        
	 	Name:	Alfonso
    J. Cervantes
	 	Title:	Chairman
	 	 	 
	 	 	 
	 	PEAH
    CAPITAL, LLC
	 	 	 
	 	By:
    	/s/
    Jake Weiser   
	 	Name:
    	Jake
    Weiser 
	 	Title:	Authorized
    Signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]